Cargando…

Obesity Drug Update: The Lost Decade?

The growing worldwide obesity epidemic and obesity-related disorders present a huge unmet medical need for safe and effective anti-obesity medications. The discovery of leptin in 1994 was rapidly succeeded by a wave of related discoveries leading to the elaboration of a hypothalamic melanocortinergi...

Descripción completa

Detalles Bibliográficos
Autores principales: Yao, Fayi, MacKenzie, Robert George
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4034063/
http://dx.doi.org/10.3390/ph3123494
_version_ 1782317923989192704
author Yao, Fayi
MacKenzie, Robert George
author_facet Yao, Fayi
MacKenzie, Robert George
author_sort Yao, Fayi
collection PubMed
description The growing worldwide obesity epidemic and obesity-related disorders present a huge unmet medical need for safe and effective anti-obesity medications. The discovery of leptin in 1994 was rapidly succeeded by a wave of related discoveries leading to the elaboration of a hypothalamic melanocortinergic neuronal circuit regulated by leptin and other central and peripheral signaling molecules to control energy homeostasis. The identification of specific neuronal subtypes along with their unique connections and expression products generated a rich target menu for anti-obesity drug discovery programs. Over the course of the last decade, several new chemical entities aimed at these targets have reached various stages or successfully completed the drug discovery/regulatory process only to be dropped or taken off the market. There are now in fact fewer options for anti-obesity drug therapies in late 2010 than were available in 2000. The challenge to discover safe and effective anti-obesity drugs is alive and well.
format Online
Article
Text
id pubmed-4034063
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-40340632014-05-27 Obesity Drug Update: The Lost Decade? Yao, Fayi MacKenzie, Robert George Pharmaceuticals (Basel) Review The growing worldwide obesity epidemic and obesity-related disorders present a huge unmet medical need for safe and effective anti-obesity medications. The discovery of leptin in 1994 was rapidly succeeded by a wave of related discoveries leading to the elaboration of a hypothalamic melanocortinergic neuronal circuit regulated by leptin and other central and peripheral signaling molecules to control energy homeostasis. The identification of specific neuronal subtypes along with their unique connections and expression products generated a rich target menu for anti-obesity drug discovery programs. Over the course of the last decade, several new chemical entities aimed at these targets have reached various stages or successfully completed the drug discovery/regulatory process only to be dropped or taken off the market. There are now in fact fewer options for anti-obesity drug therapies in late 2010 than were available in 2000. The challenge to discover safe and effective anti-obesity drugs is alive and well. MDPI 2010-11-24 /pmc/articles/PMC4034063/ http://dx.doi.org/10.3390/ph3123494 Text en © 2010 by the authors; licensee MDPI, Basel, Switzerland. http://creativecommons.org/licenses/by/3.0/ This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).
spellingShingle Review
Yao, Fayi
MacKenzie, Robert George
Obesity Drug Update: The Lost Decade?
title Obesity Drug Update: The Lost Decade?
title_full Obesity Drug Update: The Lost Decade?
title_fullStr Obesity Drug Update: The Lost Decade?
title_full_unstemmed Obesity Drug Update: The Lost Decade?
title_short Obesity Drug Update: The Lost Decade?
title_sort obesity drug update: the lost decade?
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4034063/
http://dx.doi.org/10.3390/ph3123494
work_keys_str_mv AT yaofayi obesitydrugupdatethelostdecade
AT mackenzierobertgeorge obesitydrugupdatethelostdecade